nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—CCL2—alveolus of lung—acquired immunodeficiency syndrome	0.156	0.29	CbGeAlD
Mimosine—L-Tyrosine—TAT—acquired immunodeficiency syndrome	0.0334	1	CrCbGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCL3L1—acquired immunodeficiency syndrome	0.0295	0.0688	CbGpPWpGaD
Mimosine—CCL2—endothelium—acquired immunodeficiency syndrome	0.0293	0.0544	CbGeAlD
Mimosine—SHMT1—blood plasma—acquired immunodeficiency syndrome	0.0281	0.0521	CbGeAlD
Mimosine—CCL2—blood plasma—acquired immunodeficiency syndrome	0.026	0.0483	CbGeAlD
Mimosine—TYR—retina—acquired immunodeficiency syndrome	0.0248	0.0461	CbGeAlD
Mimosine—TYR—skin of body—acquired immunodeficiency syndrome	0.0218	0.0405	CbGeAlD
Mimosine—TYR—lymphoid tissue—acquired immunodeficiency syndrome	0.0176	0.0328	CbGeAlD
Mimosine—TYR—blood—acquired immunodeficiency syndrome	0.0166	0.0308	CbGeAlD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCL4—acquired immunodeficiency syndrome	0.0161	0.0377	CbGpPWpGaD
Mimosine—CCL2—retina—acquired immunodeficiency syndrome	0.0142	0.0265	CbGeAlD
Mimosine—CCL2—skin of body—acquired immunodeficiency syndrome	0.0125	0.0232	CbGeAlD
Mimosine—SHMT1—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.012	0.0281	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.0111	0.0259	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCL3—acquired immunodeficiency syndrome	0.011	0.0258	CbGpPWpGaD
Mimosine—SHMT1—lymphoid tissue—acquired immunodeficiency syndrome	0.0109	0.0203	CbGeAlD
Mimosine—SHMT1—digestive system—acquired immunodeficiency syndrome	0.0108	0.0201	CbGeAlD
Mimosine—SHMT1—blood—acquired immunodeficiency syndrome	0.0103	0.0191	CbGeAlD
Mimosine—CCL2—lymphoid tissue—acquired immunodeficiency syndrome	0.0101	0.0188	CbGeAlD
Mimosine—CCL2—digestive system—acquired immunodeficiency syndrome	0.01	0.0186	CbGeAlD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCR2—acquired immunodeficiency syndrome	0.00997	0.0233	CbGpPWpGaD
Mimosine—SHMT1—bone marrow—acquired immunodeficiency syndrome	0.00995	0.0185	CbGeAlD
Mimosine—TYR—lymph node—acquired immunodeficiency syndrome	0.00995	0.0185	CbGeAlD
Mimosine—CCL2—GMCSF-mediated signaling events—CSF2—acquired immunodeficiency syndrome	0.00979	0.0229	CbGpPWpGaD
Mimosine—SHMT1—vagina—acquired immunodeficiency syndrome	0.00953	0.0177	CbGeAlD
Mimosine—CCL2—blood—acquired immunodeficiency syndrome	0.00953	0.0177	CbGeAlD
Mimosine—CCL2—Chemokine receptors bind chemokines—CXCL12—acquired immunodeficiency syndrome	0.00938	0.0219	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CXCR4—acquired immunodeficiency syndrome	0.00938	0.0219	CbGpPWpGaD
Mimosine—CCL2—bone marrow—acquired immunodeficiency syndrome	0.00922	0.0171	CbGeAlD
Mimosine—CCL2—spinal cord—acquired immunodeficiency syndrome	0.00918	0.0171	CbGeAlD
Mimosine—SHMT1—lung—acquired immunodeficiency syndrome	0.00902	0.0167	CbGeAlD
Mimosine—CCL2—TWEAK Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.00898	0.021	CbGpPWpGaD
Mimosine—CCL2—vagina—acquired immunodeficiency syndrome	0.00884	0.0164	CbGeAlD
Mimosine—CCL2—lung—acquired immunodeficiency syndrome	0.00836	0.0155	CbGeAlD
Mimosine—SHMT1—nervous system—acquired immunodeficiency syndrome	0.00835	0.0155	CbGeAlD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—IFNG—acquired immunodeficiency syndrome	0.00823	0.0192	CbGpPWpGaD
Mimosine—SHMT1—central nervous system—acquired immunodeficiency syndrome	0.00804	0.0149	CbGeAlD
Mimosine—CCL2—nervous system—acquired immunodeficiency syndrome	0.00774	0.0144	CbGeAlD
Mimosine—CCL2—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.00769	0.018	CbGpPWpGaD
Mimosine—CCL2—central nervous system—acquired immunodeficiency syndrome	0.00745	0.0138	CbGeAlD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00744	0.0174	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.00732	0.0171	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCL5—acquired immunodeficiency syndrome	0.00713	0.0167	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00672	0.0157	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCR5—acquired immunodeficiency syndrome	0.00643	0.015	CbGpPWpGaD
Mimosine—SHMT1—brain—acquired immunodeficiency syndrome	0.00638	0.0119	CbGeAlD
Mimosine—SHMT1—lymph node—acquired immunodeficiency syndrome	0.00617	0.0115	CbGeAlD
Mimosine—CCL2—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00608	0.0142	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.00606	0.0142	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	0.00595	0.0139	CbGpPWpGaD
Mimosine—CCL2—brain—acquired immunodeficiency syndrome	0.00591	0.011	CbGeAlD
Mimosine—CCL2—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	0.00588	0.0137	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.00582	0.0136	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	0.00578	0.0135	CbGpPWpGaD
Mimosine—CCL2—lymph node—acquired immunodeficiency syndrome	0.00572	0.0106	CbGeAlD
Mimosine—CCL2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00566	0.0132	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.00562	0.0131	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.00549	0.0128	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.00526	0.0123	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.00517	0.0121	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.00494	0.0115	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.00485	0.0113	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00451	0.0105	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.0045	0.0105	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.00442	0.0103	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00415	0.00969	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00408	0.00952	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.00402	0.00938	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.00393	0.00918	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.00381	0.00889	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.00377	0.0088	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00375	0.00877	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.00366	0.00856	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00353	0.00824	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00353	0.00824	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.0035	0.00816	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00343	0.00801	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.00341	0.00795	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.00326	0.0076	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.00319	0.00745	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	0.00311	0.00725	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0031	0.00725	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—acquired immunodeficiency syndrome	0.00304	0.0071	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.00304	0.0071	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.00292	0.00681	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.00291	0.0068	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00291	0.00679	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.00286	0.00668	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00278	0.0065	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.00275	0.00642	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00268	0.00627	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00252	0.00588	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00242	0.00565	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.00237	0.00554	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00237	0.00553	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00237	0.00553	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.00235	0.00549	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.00231	0.00539	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.0023	0.00538	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TAT—acquired immunodeficiency syndrome	0.00221	0.00516	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00212	0.00495	CbGpPWpGaD
Mimosine—SHMT1—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.00211	0.00492	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.00205	0.00478	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00192	0.00448	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.00191	0.00447	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.00188	0.0044	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00188	0.00439	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	0.00183	0.00426	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.00182	0.00425	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.0018	0.00421	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.0018	0.00421	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.0018	0.00421	CbGpPWpGaD
Mimosine—SHMT1—Disease—CCNT1—acquired immunodeficiency syndrome	0.00179	0.00419	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00176	0.00411	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00172	0.00401	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00162	0.00379	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00159	0.00372	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.00152	0.00355	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.00149	0.00348	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.00147	0.00343	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00137	0.0032	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00124	0.00289	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.0012	0.00281	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00109	0.00254	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00104	0.00243	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00104	0.00243	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000984	0.0023	CbGpPWpGaD
Mimosine—SHMT1—Disease—CXCR4—acquired immunodeficiency syndrome	0.000942	0.0022	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000941	0.0022	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000925	0.00216	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000925	0.00216	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000704	0.00164	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000693	0.00162	CbGpPWpGaD
Mimosine—SHMT1—Disease—CCR5—acquired immunodeficiency syndrome	0.000645	0.00151	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000643	0.0015	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000634	0.00148	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000581	0.00136	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000546	0.00128	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000546	0.00128	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000416	0.000971	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00041	0.000956	CbGpPWpGaD
Mimosine—SHMT1—Disease—CD4—acquired immunodeficiency syndrome	0.000405	0.000947	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000385	0.000899	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000375	0.000875	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000366	0.000855	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6—acquired immunodeficiency syndrome	0.000219	0.000512	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000216	0.000505	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000215	0.000503	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000127	0.000297	CbGpPWpGaD
